Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Azenta Inc (AZTA)

Azenta Inc (AZTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,304,248
  • Shares Outstanding, K 45,692
  • Annual Sales, $ 656,320 K
  • Annual Income, $ -164,170 K
  • EBIT $ -85 M
  • EBITDA $ 116 M
  • 60-Month Beta 1.49
  • Price/Sales 3.51
  • Price/Cash Flow 10.88
  • Price/Book 1.37

Options Overview Details

View History
  • Implied Volatility 54.27% ( +3.28%)
  • Historical Volatility 46.01%
  • IV Percentile 65%
  • IV Rank 50.54%
  • IV High 77.11% on 04/18/24
  • IV Low 30.94% on 08/30/24
  • Put/Call Vol Ratio 0.13
  • Today's Volume 18
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 1.15
  • Today's Open Interest 6,164
  • Open Int (30-Day) 5,991

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.05
  • Number of Estimates 2
  • High Estimate 0.08
  • Low Estimate 0.02
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.97 +14.69%
on 12/17/24
51.25 -1.60%
on 12/20/24
+5.78 (+12.95%)
since 11/20/24
3-Month
38.82 +29.91%
on 11/18/24
51.25 -1.60%
on 12/20/24
+1.16 (+2.35%)
since 09/20/24
52-Week
38.82 +29.91%
on 11/18/24
69.16 -27.08%
on 01/22/24
-12.11 (-19.36%)
since 12/20/23

Most Recent Stories

More News
Insider Sale: SVP and CHRO of $AZTA (AZTA) Sells 548 Shares

Olga Pirogova, the SVP and CHRO of $AZTA ($AZTA), sold 548 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.8% of their shares....

AZTA : 50.43 (+1.88%)
Brooks: Fiscal Q4 Earnings Snapshot

Brooks: Fiscal Q4 Earnings Snapshot

AZTA : 50.43 (+1.88%)
Brooks: Fiscal Q3 Earnings Snapshot

Brooks: Fiscal Q3 Earnings Snapshot

AZTA : 50.43 (+1.88%)
1 Cathie Wood Stock With 55% Upside Potential

This Ark Invest biotech stock pick, with 55% potential upside, garnered a vote of confidence from Jefferies last week.

TXG : 14.04 (+3.16%)
AZTA : 50.43 (+1.88%)
ARKG : 23.68 (+3.18%)
ARKK : 59.40 (+2.11%)
Azenta to Host GENEWIZ Week November 6-10, 2023

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ...

AZTA : 50.43 (+1.88%)
You Can't Control Activist Investors, but You Can Control What You Do About Them

Activist investors come after companies both big and small, usually looking to get management to change their ways.

AZTA : 50.43 (+1.88%)
DIS : 112.03 (+0.59%)
Azenta Announces CFO Transition

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer,...

BDX : 227.68 (+1.72%)
AZTA : 50.43 (+1.88%)
Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare...

AZTA : 50.43 (+1.88%)
Azenta to Participate in the Baird 2023 Global Healthcare Conference

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New...

AZTA : 50.43 (+1.88%)
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana...

AZTA : 50.43 (+1.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta...

See More

Key Turning Points

3rd Resistance Point 53.34
2nd Resistance Point 52.30
1st Resistance Point 51.36
Last Price 50.43
1st Support Level 49.38
2nd Support Level 48.34
3rd Support Level 47.40

See More

52-Week High 69.16
Fibonacci 61.8% 57.57
Fibonacci 50% 53.99
Last Price 50.43
Fibonacci 38.2% 50.41
52-Week Low 38.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar